🔎 Trials Near Me

Beranda › Kanker Ginjal (Karsinoma Sel Renal) › Pennsylvania › Pittsburgh

Uji klinis Kanker Ginjal (Karsinoma Sel Renal) di Pittsburgh, PA

15 studi untuk Kanker Ginjal (Karsinoma Sel Renal) mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Menerima pesertaFase 1
  • Research Site, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05536141

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Menerima pesertaFase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07419841

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Menerima pesertaFase 1/2
  • UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07049926

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Menerima pesertaFase 1
  • Exelixis Clinical Site #32, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Menerima pesertaFase 2
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
  • dan 2 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Menerima pesertaFase 2
  • Allegheny General Hospital, Pittsburgh
  • UPMC-Magee Womens Hospital, Pittsburgh
  • UPMC-Saint Margaret, Pittsburgh
  • dan 14 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Menerima pesertaFase 3
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07115043

Autologous Dendritic Cell Vaccine in Kidney Cancer

Menerima pesertaFase 2
  • UPMC Department of Urology, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05127824

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Menerima pesertaFase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Menerima pesertaFase 1
  • UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Menerima pesertaFase 1/2
  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT06413680

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Menerima pesertaFase 2
  • UPMC Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07223424

A Study of VET3-TGI in Patients With Solid Tumors

Menerima pesertaFase 1
  • UPMC- Hillman Cancer Center, Pittsburgh
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06444815

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Menerima pesertaFase 3
  • UPMC-Saint Margaret, Pittsburgh
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
  • UPMC-Shadyside Hospital, Pittsburgh
  • dan 9 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT04510597

Uji klinis Kanker Ginjal (Karsinoma Sel Renal) di kota lain

Studi lain di Pittsburgh

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.